Enhanced Datamart

Our foundational data subscriptions, Enhanced Datamarts (EDMs), cover 22 tumor types and deliver a wide pool of clinical data sourced from electronic health records.

Accelerate oncology research with real-world evidence

Flatiron Enhanced Datamarts enable researchers to monitor and analyze key aspects of the patient journey. Sourced from the electronic health records of hundreds of thousands of patients in Flatiron’s OncoEMR, these curated, longitudinal, de-identified datasets contain a combination of structured and more sophisticated abstracted, derived, and extracted data elements for 22 different cancer types.

EDMs are refreshed monthly with 30-day recency, allowing you to understand treatment journeys from diagnosis onward.

AVAILABLE DATA

22 disease-specific data models

EDMs for the following cancer types are currently available:

Acute myeloid leukemia
Early breast cancer
Metastatic breast cancer
Chronic lymphocytic leukemia
Metastatic colorectal cancer
Diffuse large B-Cell lymphoma
Advanced endometrial cancer
Follicular lymphoma
Advanced gastric/esophageal cancer
Advanced head and neck cancer
Hepatocellular carcinoma
Mantle cell lymphoma
Advanced melanoma
Multiple myeloma
Early non-small cell lung cancer
Advanced non-small cell lung cancer
Ovarian cancer
Metastatic pancreatic cancer
Metastatic prostate cancer
Metastatic renal cell carcinoma
Small cell lung cancer
Advanced urothelial carcinoma

Derive real-world endpoints using validated outcome variables

Real-world overall survival (rwOS)

Conduct robust survival analyses for studies with our validated mortality variable, available with all EDM subscriptions.

See validation study

Real-world progression-free survival (rwPFS)

Analyze real-world progression-related endpoints across observational RWE studies with our validated real-world progression variable, available with certain EDM subscriptions.

See validation study

FLEXIBLE DATA ON DEMAND

Gain greater flexibility and address more use cases, in less time

If you have an evidence need that is not being met through your subscription offering, or don’t have the time or budget to design a fully customized project, consider Data on Demand. We have tailored our foundational data solution with a menu of optional custom add-ons including reason for therapy discontinuation for select drugs, comorbidities, additional malignancies, and more.